Leqi Zhou

427 total citations
29 papers, 223 citations indexed

About

Leqi Zhou is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Leqi Zhou has authored 29 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Leqi Zhou's work include Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Leqi Zhou is often cited by papers focused on Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Leqi Zhou collaborates with scholars based in China, United States and Panama. Leqi Zhou's co-authors include Guanyu Yu, Wei Zhang, Liqiang Hao, Kuo Zheng, Zheng Lou, Bo Feng, Sen Zhang, Xianhua Gao, Xialin Yan and Zirui He and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Leqi Zhou

26 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leqi Zhou China 11 140 70 60 44 37 29 223
Aya El Helali Hong Kong 9 108 0.8× 94 1.3× 34 0.6× 59 1.3× 39 1.1× 34 288
Amanda M. Dann United States 9 133 0.9× 47 0.7× 104 1.7× 61 1.4× 23 0.6× 16 224
Jiashuo Chao China 9 116 0.8× 74 1.1× 60 1.0× 45 1.0× 31 0.8× 20 255
Kunli Du China 11 121 0.9× 122 1.7× 66 1.1× 46 1.0× 29 0.8× 25 269
Elena Molina Roldán Spain 8 68 0.5× 63 0.9× 38 0.6× 67 1.5× 30 0.8× 16 178
Joseph Tang United Kingdom 8 177 1.3× 54 0.8× 85 1.4× 48 1.1× 44 1.2× 14 322
Rainer Christoph Miksch Germany 8 165 1.2× 44 0.6× 45 0.8× 33 0.8× 79 2.1× 18 245
S Denley United Kingdom 5 180 1.3× 45 0.6× 87 1.4× 44 1.0× 36 1.0× 6 228
Zhangzhou Huang China 8 158 1.1× 78 1.1× 40 0.7× 106 2.4× 27 0.7× 19 279
Dolgormaa Gantumur Japan 9 96 0.7× 102 1.5× 56 0.9× 23 0.5× 40 1.1× 13 336

Countries citing papers authored by Leqi Zhou

Since Specialization
Citations

This map shows the geographic impact of Leqi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leqi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leqi Zhou more than expected).

Fields of papers citing papers by Leqi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leqi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leqi Zhou. The network helps show where Leqi Zhou may publish in the future.

Co-authorship network of co-authors of Leqi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Leqi Zhou. A scholar is included among the top collaborators of Leqi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leqi Zhou. Leqi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Leqi, Wanrong Man, Lidian Chen, et al.. (2025). hnRNP A1 inhibits colorectal cancer tumorigenesis and progression by regulating fatty acid metabolism and RNA stability. Cell Death Discovery. 11(1). 542–542.
2.
3.
Yu, Guanyu, et al.. (2025). New insight in immunotherapy and combine therapy in colorectal cancer. Frontiers in Cell and Developmental Biology. 12. 1453630–1453630. 4 indexed citations
5.
Liu, Jingyi, Wei Qin, Zhenghao Cai, et al.. (2025). ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Advanced Science. 12(42). e06225–e06225.
7.
Hu, Xuefei, Fuao Cao, Leqi Zhou, et al.. (2024). WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer. npj Precision Oncology. 8(1). 144–144. 5 indexed citations
8.
Zhou, Leqi, Chenguang Bai, Zhixuan Li, et al.. (2024). Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis. Cancer Letters. 602. 217181–217181. 5 indexed citations
9.
Zhou, Leqi, Xianhua Gao, Liqiang Hao, et al.. (2023). Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment. Frontiers in Immunology. 14. 1175343–1175343. 14 indexed citations
10.
Zhou, Leqi, Siyuan Jiang, Kuo Zheng, et al.. (2023). DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling Pathway. International Journal of Radiation Oncology*Biology*Physics. 117(1). 198–210. 12 indexed citations
12.
Zhou, Leqi, Xianhua Gao, Zheng Lou, et al.. (2023). Clinicopathological features and prognosis of synchronous and metachronous colorectal cancer: a retrospective cohort study. International Journal of Surgery. 109(12). 4073–4090. 4 indexed citations
13.
Yu, Guanyu, Leqi Zhou, Kuo Zheng, et al.. (2022). High expression of phosphorylated focal adhesion kinase predicts a poor prognosis in human colorectal cancer. Frontiers in Pharmacology. 13. 989999–989999. 2 indexed citations
14.
Zheng, Nanxin, Leqi Zhou, Qingying Meng, et al.. (2022). Multiregion single cell analysis reveals a novel subtype of cancer-associated fibroblasts located in the hypoxic tumor microenvironment in colorectal cancer. Translational Oncology. 27. 101570–101570. 8 indexed citations
15.
Zheng, Kuo, Qingqing Hu, Guanyu Yu, et al.. (2022). Trends of sphincter-preserving surgeries for low lying rectal cancer: A 20-year experience in China. Frontiers in Oncology. 12. 996866–996866. 5 indexed citations
16.
Qin, Wei, Hao Zhong, Yanyan Hu, et al.. (2022). Risk factors of chylous ascites and its relationship with long-term prognosis in laparoscopic D3 lymphadenectomy for right colon cancer. Langenbeck s Archives of Surgery. 407(6). 2453–2462. 2 indexed citations
17.
Zheng, Kuo, Qihang Zhang, Leqi Zhou, et al.. (2021). Machine learning-based random forest predicts anastomotic leakage after anterior resection for rectal cancer. Journal of Gastrointestinal Oncology. 12(3). 921–932. 22 indexed citations
18.
He, Zirui, Xiao Yang, Ling Huang, et al.. (2021). PSMC5 Promotes Proliferation and Metastasis of Colorectal Cancer by Activating Epithelial–Mesenchymal Transition Signaling and Modulating Immune Infiltrating Cells. Frontiers in Cell and Developmental Biology. 9. 657917–657917. 9 indexed citations
19.
Zhou, Leqi, Sen Zhang, Xia Zou, et al.. (2019). <p>The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation</p>. Cancer Management and Research. Volume 11. 6185–6199. 15 indexed citations
20.
He, Zirui, Sen Zhang, Pei Xue, et al.. (2018). Completely medial access by page-turning approach for laparoscopic right hemi-colectomy: 6-year-experience in single center. Surgical Endoscopy. 33(3). 959–965. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026